Pricing Log in Create free account

Ensysce Biosciences, Inc. (ENSC) vs Intensity Therapeutics Inc. (INTS)

Ensysce Biosciences, Inc. and Intensity Therapeutics Inc. are both Biotechnology companies. Ensysce Biosciences, Inc. and Intensity Therapeutics Inc. are of similar size ($11.6M and $11.0M). Intensity Therapeutics Inc. has the higher net margin (0.00% vs −280.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Intensity Therapeutics Inc. leads on 9 and Ensysce Biosciences, Inc. on 3.

Valuation

Metric ENSC INTS Biotechnology median
P/E n/m n/m 8.50
P/S 1.51 n/m 9.71
P/B n/m 0.98 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.03 0.64
EV/Sales 1.54 n/m 9.21
Earnings yield (530.77%) (50.85%) (33.15%)
Free cash flow yield (130.64%) (98.74%) (25.50%)

Profitability

Metric ENSC INTS Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (281.32%) 0.00% 0.00%
Net margin (280.49%) 0.00% 0.00%
Free cash flow margin (196.76%) 0.00% 0.00%
Return on equity (1,295.01%) (195.88%) (56.36%)
Return on assets (295.92%) (139.85%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENSC INTS Biotechnology median
Revenue growth (TTM) (39.29%) — 6.02%
EPS growth (last fiscal year) 65.24% 70.74% 30.26%
Revenue growth, 5-year CAGR 5.21% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENSC INTS Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 0.70 5.00 4.72
Net debt to EBITDA 0.42 0.99 0.96

Dividend

Metric ENSC INTS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ENSC INTS Biotechnology median
Market cap 11.64m 11.04m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack